Angela Talley
Chief Tech/Sci/R&D Officer bij SPERO THERAPEUTICS, INC.
Profiel
Angela Talley is currently working as the Senior Vice President of Clinical Development at Spero Therapeutics, Inc. She previously worked as the Executive Director of Clinical Development at Allergan Ltd.
Dr. Talley holds a doctorate degree from the Icahn School of Medicine at Mount Sinai.
Actieve functies van Angela Talley
| Bedrijven | Functie | Begin |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Angela Talley
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | - |
Opleiding van Angela Talley
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
